| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-63 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-63 |
| filingDate |
2010-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdcaa5e9da58e0bd8551131ee9f0d910
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7914c54bfa8c76a2a332a38001d2c31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd710a23474a75e276d55ceee144cfbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46867deb88a7190ec3351c196b8d470e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1926667625f9977503460b66e780c551 |
| publicationDate |
2012-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2010279076-A1 |
| titleOfInvention |
Motilin-like peptide compound having transmucosal absorbability imparted thereto |
| abstract |
The purpose of the present invention is to provide a motilin-like peptide compound which maintains the digestive tract motor-stimulating activity of motilin and to which a high absorbability in transmucosal administration is imparted. For this purpose, motilin derivatives are designed and synthesized while considering the degradation passage of motilin at a transmucosal absorption site and the maintenance of the physiological activity of motilin. As a result, it is confirmed that a compound, which is characterized by having an amino acid substitution at the 21-position of natural motilin, shows a high absorbability in transmucosal administration and maintains the same activity as motilin. Thus, the present invention has been completed. |
| priorityDate |
2009-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |